GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1176 - 1200 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgM Patient 1 10 moderate
G68703KI
31
IgM Patient 1 22 moderate
G68703KI
53
IgG Patient 1 6 moderate
G68703KI
43
IgM Patient 1 6 moderate
G68703KI
28
IgA Patient 2 15 mild
G68703KI
357
IgA Patient 2 24 mild
G68703KI
391
IgG Patient 2 15 mild
G68703KI
4110
IgG Patient 2 24 mild
G68703KI
4116
IgM Patient 2 15 mild
G68703KI
106
IgM Patient 2 24 mild
G68703KI
115
IgA Patient 2 3 mild
G68703KI
389
IgG Patient 2 3 mild
G68703KI
7132
IgM Patient 2 3 mild
G68703KI
151
IgA Patient 3 -180 mild
G68703KI
2658
IgA Patient 3 11 mild
G68703KI
2748
IgG Patient 3 -180 mild
G68703KI
3666
IgM Patient 3 -180 mild
G68703KI
7539
IgA Patient 3 4 mild
G68703KI
2769
IgG Patient 3 11 mild
G68703KI
4801
IgG Patient 3 4 mild
G68703KI
5185
IgM Patient 3 11 mild
G68703KI
8187
IgM Patient 3 4 mild
G68703KI
8163
IgA Patient 4 12 mild
G68703KI
447
IgG Patient 4 12 mild
G68703KI
139
IgM Patient 4 12 mild
G68703KI
301

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024